Literature DB >> 26984627

Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.

Monica Betta1, Marco Laurino2, Andrea Pugliese3, Giorgio Guzzetta4, Alberto Landi5, Piero Manfredi6.   

Abstract

Herpes zoster arises from reactivation of the varicella-zoster virus (VZV), causing varicella in children. As reactivation occurs when cell-mediated immunity (CMI) declines, and there is evidence that re-exposure to VZV boosts CMI, mass varicella immunization might increase the zoster burden, at least for some decades. Fear of this natural zoster boom is the main reason for the paralysis of varicella immunization in Europe. We apply optimal control to a realistically parametrized age-structured model for VZV transmission and reactivation to investigate whether feasible varicella immunization paths that are optimal in controlling both varicella and zoster exist. We analyse the optimality system numerically focusing on the role of the cost functional, of the relative zoster-varicella cost and of the planning horizon length. We show that optimal programmes will mostly be unfeasible for public health owing to their complex temporal profiles. This complexity is the consequence of the intrinsically antagonistic nature of varicella immunization programmes when aiming to control both varicella and zoster. However, we show that gradually increasing-hence feasible-vaccination schedules can perform better than routine programmes with constant vaccine uptake. Finally, we show the optimal profiles of feasible programmes targeting mitigation of the post-immunization natural zoster boom with priority.
© 2016 The Author(s).

Entities:  

Keywords:  herpes zoster; immunity boosting; mass vaccination; optimal control; varicella

Mesh:

Year:  2016        PMID: 26984627      PMCID: PMC4810870          DOI: 10.1098/rspb.2016.0054

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  24 in total

1.  Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

Authors:  Albert Jan van Hoek; Alessia Melegaro; Emelio Zagheni; W John Edmunds; Nigel Gay
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

2.  Modelling the impact of varicella vaccination on varicella and zoster.

Authors:  M Karhunen; T Leino; H Salo; I Davidkin; T Kilpi; K Auranen
Journal:  Epidemiol Infect       Date:  2009-10-02       Impact factor: 2.451

3.  Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.

Authors:  Benson Ogunjimi; Evelien Smits; Niel Hens; Annick Hens; Kevin Lenders; Margareta Ieven; Viggo Van Tendeloo; Pierre Van Damme; Philippe Beutels
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

4.  The health and economic burden of chickenpox and herpes zoster in Belgium.

Authors:  J Bilcke; B Ogunjimi; C Marais; F de Smet; M Callens; K Callaert; E van Kerschaver; J Ramet; P van Damme; P Beutels
Journal:  Epidemiol Infect       Date:  2012-01-10       Impact factor: 2.451

5.  Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination.

Authors:  Jessica Leung; Rafael Harpaz; Noelle-Angelique Molinari; Aisha Jumaan; Fangjun Zhou
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

6.  Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)?

Authors:  Jacques Gaillat; Vincent Gajdos; Odile Launay; Denis Malvy; Bruno Demoures; Lucie Lewden; Sybil Pinchinat; Tarik Derrough; Claudine Sana; Evelyne Caulin; Benoît Soubeyrand
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

7.  The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Authors:  Rachel Civen; Sandra S Chaves; Aisha Jumaan; Han Wu; Laurene Mascola; Paul Gargiullo; Jane F Seward
Journal:  Pediatr Infect Dis J       Date:  2009-11       Impact factor: 2.129

8.  Optimal control strategy for prevention of avian influenza pandemic.

Authors:  Eunok Jung; Shingo Iwami; Yasuhiro Takeuchi; Tae-Chang Jo
Journal:  J Theor Biol       Date:  2009-06-06       Impact factor: 2.691

Review 9.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

10.  Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.

Authors:  Piero Poletti; Alessia Melegaro; Marco Ajelli; Emanuele Del Fava; Giorgio Guzzetta; Luca Faustini; Giampaolo Scalia Tomba; Pierluigi Lopalco; Caterina Rizzo; Stefano Merler; Piero Manfredi
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more
  5 in total

1.  Optimal time-profiles of public health intervention to shape voluntary vaccination for childhood diseases.

Authors:  Bruno Buonomo; Piero Manfredi; Alberto d'Onofrio
Journal:  J Math Biol       Date:  2018-11-02       Impact factor: 2.259

Review 2.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

3.  Exploring the Seasonal Drivers of Varicella Zoster Virus Transmission and Reactivation.

Authors:  Kevin M Bakker; Marisa C Eisenberg; Robert Woods; Micaela E Martinez
Journal:  Am J Epidemiol       Date:  2021-09-01       Impact factor: 5.363

4.  Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.

Authors:  Ellen Rafferty; Wade McDonald; Weicheng Qian; Nathaniel D Osgood; Alexander Doroshenko
Journal:  PeerJ       Date:  2018-06-20       Impact factor: 2.984

Review 5.  Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways.

Authors:  Wenjin Zheng; Qing Xu; Yiyuan Zhang; Xiaofei E; Wei Gao; Mogen Zhang; Weijie Zhai; Ronaldjit Singh Rajkumar; Zhijun Liu
Journal:  Virol J       Date:  2020-12-09       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.